申请人:Abbott Laboratories
公开号:US05180733A1
公开(公告)日:1993-01-19
Compounds of the formula: ##STR1## or a pharmaceutically acceptable salt thereof, wherein M is 0, 1 or 2 and n is 0 or 1; R.sup.1 is hydrogen or lower alkyl; R.sup.2 is C.sub.1 -C.sub.6 -alkyl substituted with a heterocyclic group or C.sub.7 -C.sub.16 -arylalkyl, wherein the aryl group is unsubstituted or substituted with from one to three non-hydrogen members independently selected from the group consisting of halogen, C.sub.1 -C.sub.6 -alkyl, halo-C.sub.1 -C.sub.6 -alkyl, C.sub.1 -C.sub.6 -alkoxy, hydroxy, amino and C.sub.1 -C.sub.6 -alkylamino; R.sup.3, R.sup.4, R.sup.5 and R.sup.6 are independently selected from the group consisting of hydrogen, C.sub.1 -C.sub.6 -alkoxy, C.sub.1 -C.sub.6 -alkyl, halogen, and halo-C.sub.1 -C.sub.6 -alkyl, or any two of R.sup.3, R.sup.4, R.sup.5 and R.sup.6 taken together form a methylenedioxy group; and R.sup.7 is hydrogen or C.sub.1 -C.sub.6 -alkyl. These compounds are useful as inhibitors of the neuronal uptake of biogenic amines and for the treatment of affective disorders, such as, for example, depression.
该化合物的公式为:##STR1## 或其药学上可接受的盐,其中M为0、1或2,n为0或1;R.sup.1为氢或较低的烷基;R.sup.2为带有杂环基团的C.sub.1-C.sub.6烷基或C.sub.7-C.sub.16芳基烷基,其中芳基未取代或由一到三个非氢成员独立选择的卤素,C.sub.1-C.sub.6烷基,卤代C.sub.1-C.sub.6烷基,C.sub.1-C.sub.6烷氧基,羟基,氨基和C.sub.1-C.sub.6烷基氨基取代;R.sup.3、R.sup.4、R.sup.5和R.sup.6独立选择自氢,C.sub.1-C.sub.6烷氧基,C.sub.1-C.sub.6烷基,卤素和卤代C.sub.1-C.sub.6烷基的群,或R.sup.3、R.sup.4、R.sup.5和R.sup.6中的任意两个形成亚甲二氧基基团;R.sup.7为氢或C.sub.1-C.sub.6烷基。这些化合物可用作生物胺神经摄取抑制剂,并用于治疗情感障碍,例如抑郁症。